12
Treatment
Respond
to aberrant
behaviors
• Reconsideration of treatment to determine
whether nonopioid therapies can be better
used
• Reconsideration
of treatment
to determine
whether
nonopioid
therapies can be
better used
• Refills limited or
not permitted
• Small frequent
prescriptions
• No concurrent
use of more than
one opioid (eg,
no prescription
of a second
short-acting drug
for breakthrough
pain in those
prescribed a
long-acting drug
for daily use)
• Mandated
consultation
with addiction
specialists/
psychiatrist
a
e level of risk conferred is indicated by the presence of one or more factors itemized
in the corresponding risk categories.
Table 4. Risk Stratification and Adherence Monitoring
(cont'd)
